Searched for
OLOPATADINE
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Dr Reddy's shares jump 5% despite 14% YoY fall in Q3 profit. Should you buy, sell or hold?Dr Reddy's shares: The company posted a 14% year-on-year decline in consolidated net profit to Rs 1,210 crore.
- Dr Reddy's Laboratories Q3 Results: Profit falls 14% YoY to Rs 1,210 crore, revenue up 4%Dr Reddy’s Laboratories reported a 14% YoY drop in Q3 net profit to Rs 1,210 crore, even as revenue rose 4% to Rs 8,727 crore. Lower margin...
- Dr Reddy's launches generic OTC ophthalmic solution in US marketDr Reddy's Laboratories has launched a new eye drop in the United States. This over-the-counter solution treats itchy eyes. It is an antihi...
- Stocks in news: Angel One, Tata Steel, Shriram Finance, IndiGo, EternalMarkets extended their corrective phase on Wednesday, with the Nifty nearing support levels. Several companies are in focus today due to si...
- Glenmark’s nasal spray Ryaltris gets China’s NMPA nod for allergic rhinitis; to be commercialised by Grand PharmaRyaltris is a fixed-dose combination of olopatadine, an antihistamine and mometasone furoate, a corticosteroid to treat the symptoms of all...
- Glenmark arm recalls products in US for manufacturing issuesGlenmark Pharmaceuticals is recalling 45,504 bottles of Ryaltris Nasal Spray and 11,568 tubes of Ciclopirox Gel in the US due to manufactur...
- Big movers on D-Street: What should investors do with ONGC, Glenmark Pharma and Reliance Power?The domestic market saw a significant boost as the Sensex surged 384 points to a new high of 84,928, and Nifty reached a record peak of 25,...
- Glenmark's partner Hikma launches specialty drug Ryaltris in USRyaltris is the only fixed-dose combination of olopatadine hydrochloride and mometasone furoate approved by the USFDA for the treatment of ...
- Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US"The over-the-counter market has long been an important segment of Glenmark's portfolio around the world. Our acquisition of these ANDAs re...
- Dr Reddy's Laboratories launches over-the-counter eye allergy drop in USDr Reddy's said Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2 per cent and 0.1 per cent, are indicated for the temporary relief of...
- Glenmark Pharma says USFDA has issued CRL for RyaltrisThe CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing faciliti...
- Alembic Pharmaceuticals gets USFDA nod for ophthalmic solutionThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solut...
- Fifteen stocks in focus on Tuesday, 4 July 2017Tata Power has completed construction of a 187 MW hydro project in Georgia
- Aurobindo Pharma gets USFDA nod for its conjunctivitis drugAurobindo Pharma has received approval from the USFDA nod for generic Olopatadine Hydrochloride ophthalmic solution used for treatment of c...
- Wockhardt gets USFDA nod for generic eye dropsDrug maker Wockhardt said it has received tentative approval from the US health regulator to market Olopatadine hydrochloride eye drops in ...
- Wockhardt receives USFDA approval for generic eye dropsDrug maker Wockhardt today said it has received tentative approval from the US health regulator.
Load More
